A European survey of noninvasive ventilation practices.
Although noninvasive ventilation (NIV) is becoming very popular, little is known about its pattern of clinical and technical utilisation in different environments. We conducted a web-based survey in Europe to identify the perceived pattern of NIV utilisation and the reason for choosing a specific ventilator and interface type in four common clinical scenarios: acute hypercapnic respiratory failure (AHRF), cardiogenic pulmonary oedema (CPE), de novo hypoxic respiratory failure and weaning/post-extubation failure (W/PE). A response was obtained from 272 (51.3%) out of 530 selected European physicians involved in NIV practice. The NIV utilisation rate was higher for pulmonologists than intensivists/anesthesiologists (p<0.05). The most common indication for all the physicians was AHRF (48%). Physicians were more likely to use NIV dedicated ventilator in AHRF and CPE and an intensive care unit (ICU) ventilator with NIV module in de novo hypoxic respiratory failure and W/PE, mainly because of the possibility of using the double circuit and inspiratory oxygen fraction control. Overall, the oro-nasal mask was the most frequently used interface, irrespective of clinical scenarios. The use of NIV in Europe is generally relatively high, especially among pulmonologists and in AHRF. Dedicated NIV ventilators and ICU ventilators with NIV modules are preferably in AHRF and in de novo hypoxic respiratory failure, respectively, together with oro-nasal masks.
Crimi
C
C
Dept of Internal and Specialistic Medicine, Section of Respiratory Diseases, University of Catania, Catania, Italy.
Noto
A
A
Princi
P
P
Esquinas
A
A
Nava
S
S
D000776:Anesthesiology / Q000379:methods; D003422:Critical Care; D005060:Europe; D006801:Humans; D006935:Hypercapnia / Q000628:therapy*; D000860:Hypoxia / Q000209:etiology; D020407:Internet; D015999:Multivariate Analysis; D011654:Pulmonary Edema / Q000628:therapy*; D015272:Pulmonary Medicine / Q000379:methods*; D012121:Respiration, Artificial / Q000009:adverse effects / Q000379:methods*; D012131:Respiratory Insufficiency / Q000628:therapy*; D011795:Surveys and Questionnaires